Loyal Announces $45 Million Series B Financing to Continue Development of First FDA-Approved Dog Lifespan Extension Drug for Veterinary Use
Bain Capital Ventures Led the Funding Round; Brings Total Funds Raised to Over $125 Million March 21, 2024 12:00 PM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Loyal, a biotech company pioneering longevity drugs for dogs, today…